Plasminogen Activator Inhibitor-1 and the Calculus of Mortality After Myocardial Infarction

This publication has 11 references indexed in Scilit:

• Acute Release of Plasminogen Activator Inhibitor-1 in ST-Segment Elevation Myocardial Infarction Predicts Mortality
  Circulation, 2003
• Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year
  Journal of the American College of Cardiology, 1995
• Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis.
  Journal of Clinical Investigation, 1995
• Activation of neurohumoral systems following acute myocardial infarction
  The American Journal of Cardiology, 1991
• Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta.
  Journal of Clinical Investigation, 1991
• Circadian Variation of Fibrinolytic Activity in Blood
  Chronobiology International, 1991
• Role of left ventricular dysfunction in neurohumoral activation in the recovery phase of anterior wall acute myocardial infarction
  The American Journal of Cardiology, 1990
• PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
  The Lancet, 1987
• Metformin Decreases the High Plasminogen Activator Inhibition Capacity, Plasma Insulin and Triglyceride Levels in Non-Diabetic Obese Subjects
  Thrombosis and Haemostasis, 1987
• Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1.
  Journal of Clinical Investigation, 1986